Globus Medical, Inc. (GMED): Valuation
TTM figures as of June 30, 2026
Globus Medical, Inc. trades at 18.6 times trailing earnings and a 7.59% free-cash-flow yield. On P/E that is higher than 7% of its own month-end history back to 2012. The Healthcare median P/E is 22.9.
Earnings yield 5.38%. Shareholder yield 2.22%. ROIC 12.4%. Piotroski F-score 9 of 9. Net cash $594.4M.
169 month-end valuation observations are on file, starting August 2012.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is GMED cheap versus its own history?
Globus Medical, Inc. trades at 18.6 times trailing earnings and a 7.59% free-cash-flow yield. On P/E that is higher than 7% of its own month-end history back to 2012. The Healthcare median P/E is 22.9.
What is GMED's free-cash-flow yield?
Globus Medical, Inc. currently yields 7.59% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.